Literature DB >> 17631078

Comparison of defibrillation efficacy and survival associated with right versus left pectoral placement for implantable defibrillators.

Michael R Gold1, Hue-Teh Shih, John Herre, David Breiter, Yunlong Zhang, Mark Schwartz.   

Abstract

The preferred location for an implantable cardioverter-defibrillator (ICD) generator is the left pectoral region as a result of the shock vector formed by the active can and the lead system. However, a right pectoral site is necessary when left-sided implantation is contraindicated. The Low Energy Safety Study was a prospective, randomized trial conducted to assess chronic defibrillation efficacy in 627 patients, including 37 (5.9%) who received right pectoral implants and 590 (94.1%) who received left pectoral implants. Patients were followed for a mean of 24 +/- 13 months. There were no significant differences observed between patients who received left versus right pectoral implants in age, gender, indications, New York Heart Association classification, or ejection fraction. Patients who received a right pectoral implant had higher defibrillation thresholds at implantation (10.6 +/- 3.8 J) than those who received a left pectoral implant (8.9 +/- 4.2 J, p = 0.01) despite similar shock impedances. The conversion efficacy for spontaneous arrhythmia episodes among patients who received right and left pectoral implants were not significantly different (33 of 33 [100%] vs 255 of 263 [97%], respectively; p = 0.31). In addition, the conversion efficacy for induced ventricular fibrillation episodes were also similar (187 of 188 [99%] on the right vs 2429 of 2475 [98%] on the left, p = 0.18). However, the all-cause mortality rate was higher for patients who received right-sided implants (hazard ratio 1.93, p <0.004). In conclusion, defibrillation thresholds are higher with right pectoral implants compared with left-sided implants, but with a proper energy safety margin, there are no significant differences in spontaneous or induced shock conversion efficacy. However, the near doubling of the mortality rate among patients with right-sided implants needs to be considered when recommending such device therapy.

Entities:  

Mesh:

Year:  2007        PMID: 17631078     DOI: 10.1016/j.amjcard.2007.02.087

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  12 in total

Review 1.  Dual- versus single-coil implantable defibrillator leads: review of the literature.

Authors:  Jörg Neuzner; Jörg Carlsson
Journal:  Clin Res Cardiol       Date:  2012-01-10       Impact factor: 5.460

Review 2.  The Saga of Defibrillation Testing: When Less Is More.

Authors:  Marye J Gleva; Melissa Robinson; Jeanne Poole
Journal:  Curr Cardiol Rep       Date:  2018-05-05       Impact factor: 2.931

3.  Reducing cardiac implantable electronic device-induced artefacts in cardiac magnetic resonance imaging.

Authors:  Aino-Maija Vuorinen; Lauri Lehmonen; Jarkko Karvonen; Miia Holmström; Sari Kivistö; Touko Kaasalainen
Journal:  Eur Radiol       Date:  2022-08-27       Impact factor: 7.034

4.  High defibrillation threshold with right-sided ICD implantation was resolved by a dual coil lead via persistent left superior vena cava.

Authors:  Takefumi Fujito; Daigo Nagahara; Taro Tsuzuki; Naoyuki Kamiyama; Atsushi Mochizuki; Tetsuji Miura
Journal:  J Cardiol Cases       Date:  2021-11-22

5.  Right-sided cardiac resynchronization therapy with defibrillator implantation in a patient with corrected transposition of great arteries and persistent left superior vena cava.

Authors:  Yuka Taguchi; Katsumi Matsumoto; Toshiyuki Ishikawa; Yutaka Ogino; Hirooki Matsushita; Junya Hosoda
Journal:  J Cardiol Cases       Date:  2017-01-13

6.  Periprocedural considerations during implantation of ICD in a patient with Dextrocardia.

Authors:  Farid Aliyev; Cengizhan Turkoglu; Isil Uzunhasan; Cengiz Celiker
Journal:  Indian Pacing Electrophysiol J       Date:  2010-01-07

7.  Use of a tunneling technique to achieve a lower defibrillation threshold during implantable cardioverter defibrillator implantation via the right subclavian vein.

Authors:  Jin-Bae Kim; Boyoung Joung; Moon-Hyoung Lee; Sung-Soon Kim
Journal:  J Korean Med Sci       Date:  2010-09-17       Impact factor: 2.153

8.  Successful dual chamber ICD implantation via a persistent left superior vena cava after ratchet syndrome.

Authors:  Naofumi Anjo; Shiro Nakahara; Tohru Kamijima; Yuichi Hori; Ayako Nakagawa; Naoki Nishiyama; Kouta Yamada; Takaaki Komatsu; Sayuki Kobayashi; Yoshihiko Sakai; Isao Taguchi
Journal:  J Arrhythm       Date:  2016-02-06

9.  Significance of intraoperative testing in right-sided implantable cardioverter-defibrillators.

Authors:  Andreas Keyser; Michael K Hilker; Ekrem Ucer; Sigrid Wittmann; Christof Schmid; Claudius Diez
Journal:  J Cardiothorac Surg       Date:  2013-04-11       Impact factor: 1.637

10.  Low efficacy of cardioversion of persistent atrial fibrillation with the implantable cardioverter-defibrillator.

Authors:  I Limantoro; K Vernooy; B Weijs; R Pisters; L Debie; H J Crijns; Y Blaauw
Journal:  Neth Heart J       Date:  2013-12       Impact factor: 2.380

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.